Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bio3DModel is an Italian healthcare-focused 3D printing and biomedical modeling company within SolidWorld Group. The company provides patient-specific anatomical models, medical 3D printing services, software, and training to support diagnosis, surgical planning, medical education, and related healthcare applications. Bio3DModel appears to operate as a commercial services and medical-technology business rather than a therapeutic drug developer, so it does not have a traditional biopharma pipeline. In 2025, the company announced ISO 13485 certification, indicating a quality management system aligned with medical-device standards. Its positioning is best understood as a specialized medical 3D printing and digital anatomy services provider serving hospitals, clinicians, and the broader medical sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bio3DModel.